search
Back to results

Lifestyle Changes in Patients With Type 2 Diabetes Mellitus and Hypertension

Primary Purpose

Blood Pressure

Status
Terminated
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
DASH diet plus exercise
ADA diet
Sponsored by
Hospital de Clinicas de Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Blood Pressure focused on measuring diabetes, exercise, DASH diet, ABPM

Eligibility Criteria

30 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patients

Inclusion Criteria:

  • type 2 diabetes
  • Blood pressure ≥140/90 mm Hg
  • ABMP ≥ 135/85 mm Hg

Exclusion Criteria:

  • digestive disease with malabsorption
  • diabetic neuropathy with gastroparesis
  • BMI ≥ 40 kg/m²

Sites / Locations

  • Hospital de Clínicas de Porto Alegre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

DASH diet

ADA DIET

Arm Description

DASH DIET + EXERCISE

DIET ACCORDING AMERICAN DIABETES ASSOCIATION DIETARY RECOMMENDATIONS FOR DIABETES

Outcomes

Primary Outcome Measures

Change from Baseline in Blood Pressure at 4 weeks
Ambulatory Blood Pressure Monitoring (ABPM) at baseline and after 4 weeks

Secondary Outcome Measures

Change from Baseline in glucose control at 4 weeks
A1 C test at baseline and after 4 weeks

Full Information

First Posted
August 3, 2011
Last Updated
January 25, 2017
Sponsor
Hospital de Clinicas de Porto Alegre
search

1. Study Identification

Unique Protocol Identification Number
NCT01461330
Brief Title
Lifestyle Changes in Patients With Type 2 Diabetes Mellitus and Hypertension
Official Title
Lifestyle Changes in Patients With Type 2 DM and Hypertension: DASH Diet and Exercise Effects
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Terminated
Study Start Date
February 2011 (Actual)
Primary Completion Date
October 2013 (Actual)
Study Completion Date
November 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital de Clinicas de Porto Alegre

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Data obtained in hypertensive patients without diabetes suggest that increased association of non-pharmacological treatment in patients with diabetes and hypertension may be associated with an improvement in blood pressure control. Despite the beneficial results found, is not yet known the magnitude of the effect of a DASH diet associated with the stimulus of physical activity on BP in patients with type 2 diabetes. The beneficial effects on blood pressure of an additional non-pharmacological intervention to drug therapy may have an even greater impact in patients with treatment-resistant hypertension The aim of this study is to evaluate the effect of changes in lifestyle on blood pressure in patients with type 2 diabetes and hypertension resistant to treatment.
Detailed Description
The aim of this study is to evaluate the effect of changes in lifestyle on blood pressure in patients with type 2 diabetes and hypertension. Secondary objectives are: Assess whether the prescription of a DASH-type diet and encouragement for physical activity through use of pedometers, can improve blood pressure control in patients with type 2 diabetes and hypertension resistant to treatment. Forty type 2 diabetic with resistant hypertension outpatients were included in a randomized clinical trial: treatment 1- DASH diet + encouragement for physical activity through use of pedometer; treatment 2- ADA diet + usual exercises. The duration of each treatment are four weeks. The patients included should have performed Ambulatory Blood Pressure Monitoring (ABPM) to exclude white-coat effect, ie when there are abnormal in the measurement of office blood pressure (equal to or above 140/90 mm Hg) and normal blood pressure by ABPM during the awake period (equal to or below 135/85 mm Hg). Twenty-four hour records with concurrent 24h urinary collections (protein intake estimative), clinical and laboratory evaluation were performed at baseline and after 4 weeks. Serum fatty acids were measured in total lipids by gas chromatography.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Blood Pressure
Keywords
diabetes, exercise, DASH diet, ABPM

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
intervention: DASH diet plus exercise DASH diet adapted to the usual diet of Brazilian type 2 diabetic patients = prescription of a normocaloric diet including fruits, vegetables, grain products, low fat dairy foods, legumes, without sugar, and with limited fat Exercises: the recommended physical activity will consist of using a pedometer during the experimental period. active comparator = ADA diet = Adoption of ADA diet.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DASH diet
Arm Type
Experimental
Arm Description
DASH DIET + EXERCISE
Arm Title
ADA DIET
Arm Type
Active Comparator
Arm Description
DIET ACCORDING AMERICAN DIABETES ASSOCIATION DIETARY RECOMMENDATIONS FOR DIABETES
Intervention Type
Other
Intervention Name(s)
DASH diet plus exercise
Other Intervention Name(s)
LYFESTYLE INTERVENTION
Intervention Description
DASH diet adapted to the usual diet of Brazilian type 2 diabetic patients = prescription of a normocaloric diet including fruits, vegetables, grain products, low fat dairy foods, legumes, without sugar, and with limited fat Exercises: the recommended physical activity will consist of using a pedometer during the experimental period.
Intervention Type
Other
Intervention Name(s)
ADA diet
Other Intervention Name(s)
Active comparator: ADA DIET
Intervention Description
Adoption of ADA diet.
Primary Outcome Measure Information:
Title
Change from Baseline in Blood Pressure at 4 weeks
Description
Ambulatory Blood Pressure Monitoring (ABPM) at baseline and after 4 weeks
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Change from Baseline in glucose control at 4 weeks
Description
A1 C test at baseline and after 4 weeks
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Patients Inclusion Criteria: type 2 diabetes Blood pressure ≥140/90 mm Hg ABMP ≥ 135/85 mm Hg Exclusion Criteria: digestive disease with malabsorption diabetic neuropathy with gastroparesis BMI ≥ 40 kg/m²
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tatiana P de Paula, RD
Organizational Affiliation
Hospital de Clínicas de Porto Alegre
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Luciana Verzoça, MD
Organizational Affiliation
Hospital de Clínicas de Porto Alegre
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande do Sul
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Lifestyle Changes in Patients With Type 2 Diabetes Mellitus and Hypertension

We'll reach out to this number within 24 hrs